VivoSeq
Other

Arthroscopic Shoulder Surgery

0

Pipeline Programs

2

Active Trials

1

Companies Involved

Arthroscopic Shoulder Surgery is an early-stage landscape with 0 programs across 1 company. The most active players are Capstone Therapeutics.

Pipeline Metrics

Competitive Density

10/100

Pipeline Velocity

6/100

Mech. Concentration

N/A

Completion Rate

93/100

Attrition Rate

6/100

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

Programs by Phase

No pipeline programs currently tracked for this disease.

Trial Status

17

clinical trials

Completed13 · 76%
Unknown status1 · 6%
Terminated1 · 6%
Recruiting1 · 6%
Not yet recruiting1 · 6%

Trial Activity

17 trials

Page 1 of 2

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)